In vitro activity of rabeprazole compared with omeprazole in Helicobacter pylori clinical isolates

被引：0
|
作者：
Lopez-Brea, M
Domingo, D
Martinez, M
Escudero, E
Jimenez, S
Alarcon, T
机构：
[1] Hosp Princesa, Madrid, Spain
[2] Hosp Nino Jesus, Madrid, Spain
来源：
GUT | 2001年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
128
引用
收藏
页码：A7 / A7
页数：1
相关论文
共 50 条
  • [31] SUPPRESSION OF HELICOBACTER-PYLORI DURING THE CLINICAL USE OF OMEPRAZOLE
    DAW, MA
    DEEGAN, P
    BEATTIE, S
    LEEN, E
    KEANE, CT
    OMORAIN, C
    GUT, 1990, 31 (10) : A1199 - A1199
  • [32] ACTIVITY OF OMEPRAZOLE ON HELICOBACTER-PYLORI AND RELATION TO TOXICITY OF STRAINS
    FIGURA, N
    ARMELLINI, D
    BUGNOLI, M
    BAYELI, PF
    GENNARI, C
    CRABTREE, JE
    JOURNAL OF CLINICAL PATHOLOGY, 1994, 47 (05) : 440 - 442
  • [33] In-vitro susceptibility of Helicobacter pylori to ampicillin, clarithromycin, metronidazole and omeprazole
    Loo, VG
    Fallone, CA
    De Souza, E
    Lavallée, J
    Barkun, AN
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (06) : 881 - 883
  • [34] In vitro activities of rabeprazole, a novel proton pump inhibitor, and its thioether derivative alone and in combination with other antimicrobials against recent clinical isolates of Helicobacter pylori
    Kawakami, Y
    Akahane, T
    Yamaguchi, M
    Oana, K
    Takahashi, Y
    Okimura, Y
    Okabe, T
    Gotoh, A
    Katsuyama, T
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) : 458 - 461
  • [35] IN VITRO ANTIMICROBIAL ACTIVITY OF RIFABUTIN AGAINST METRONIDAZOLE-RESISTANT HELICOBACTER PYLORI ISOLATES
    Siavoshi, F.
    Bolandi, Z.
    Malekzadeh, R.
    Eyvazi, S.
    Honarmand, S.
    HELICOBACTER, 2012, 17 : 107 - 107
  • [36] MUTUAL EFFECTS OF ANTIMICROBIAL COMBINATION AGAINST CLINICAL ISOLATES OF RESISTANT HELICOBACTER PYLORI IN VITRO
    Song, C.
    Xie, Y.
    Liu, D.
    Zhou, X.
    Guo, M.
    HELICOBACTER, 2014, 19 : 149 - 149
  • [37] Susceptibility of Helicobacter pylori isolates to metronidazole, clarithromycin and amoxycillin in vitro and in clinical treatment in Japan
    Miyaji, H
    Azuma, T
    Ito, S
    Suto, H
    Ito, Y
    Yamazaki, Y
    Sato, F
    Hirai, M
    Kuriyama, M
    Kato, T
    Kohli, Y
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (06) : 1131 - 1136
  • [38] The effects of antimicrobial combination against antibiotic resistant Helicobacter pylori of clinical isolates in vitro
    Song, Cong Hua
    Xie, Yong
    Liu, Dongsheng
    Zhou, Xiaojiang
    Guo, Mengmeng
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 233 - 233
  • [39] Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection -: comparison with omeprazole and lansoprazole
    Miwa, H
    Ohkura, R
    Murai, T
    Sato, K
    Nagahara, A
    Hirai, S
    Watanabe, S
    Sato, N
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (06) : 741 - 746
  • [40] Comparison of standard dose rabeprazole and double dose omeprazole in PPI-based triple therapy for Helicobacter pylori infection - A randomized clinical trial
    Kuwayama, H
    Takahashi, M
    Takada, H
    Luk, G
    GASTROENTEROLOGY, 2001, 120 (05) : A584 - A584
12345